Background and Aims. Morphogenesis of the upper lip and palate is a complex process involving highly regulated interactions between epithelial and mesenchymal cells. Genetic evidence in humans and mice indicates the involvement of matrix metalloproteinases (MMPs) and their endogenous tissue inhibitors (TIMPs) in cleft lip palate (CLP) aetiology. This study investigated whether expression of MMP-2, MMP-8, MMP-9, TIMP-2, and TIMP-4, which are essential for the upper lip and palate fusion, is dysregulated in children with CLP. Methods. Oral mucosa tissue samples were obtained from patients with complete unilateral (CU) CLP (n = 25) and complete bilateral (CB) CLP (n = 19) during corrective plastic surgery and in unaffected control subjects (n = 10). MMPs and TIMPs expression was assessed by immunohistochemistry, and the data were analyzed using the Kruskal -Wallis test with the Bonferroni correction. Results. In CLP patients, MMP-2, TIMP-2 immunoreactivity in the oral mucosa was seen to have a few to abundant structures, but the overall number of MMP-2, TIMP-2-positive structures was greater than that in controls (P < 0.01). The total number of TIMP-4, MMP-9-positive cells showed a significant decrease in the CBCLP compared with that of CUCLP (P < 0.001). MMP-8 expression trends in the CLP group were similar to those of the control group. Conclusions. The results suggest that TIMP-4 and MMP-9 are the main ECM remodeling regulatory proteins expressed in CUCLP affected tissues of the oral mucosa. The increased expression of MMP-2 and TIMP-2 in CLP tissues implicates these factors in the regulation of cell migration during ECM turnover independently of different types of clefts. Investigation of MMP and TIMP expression in tissue samples from patients with CLP appears to be a promising approach to the etiopathogenesis of CLP.
INTRODUCTION
Craniofacial anomalies, in particular cleft lip and palate (CLP), are the most prevalent birth defects in humans with a worldwide frequency of 1 in 500 to 1000 livebirths 1 . About 70% of cases are considered non-syndromic CLP (NSCLP), whereas the remaining approximately 30% of CLP are syndromic 2 . Clinically, cleft lip and palate is a unilateral or bilateral gap between the philtrum and the lateral upper lip.
The etiology of this pathology has only been partially explained to date. In both humans and mice, it is known that environmental and epigenetic factors affect NSCLP susceptibility 3 . However, in most non-syndromic cases, the cause remains unknown. CLP is characterized by the incomplete fusion of the lip, alveolus, and hard and soft palates, with the most severe clefts extending completely through both soft tissue and bone. The mechanisms for explaining the incomplete fusion of the facial structures are complex and not fully understood. Three main mechanisms have been proposed: programmed cell death 4 , cell migration to the oral and nasal side of the palate 5 , and epithelial-mesenchymal transdifferentiation 6 . Normal development of the lip and palate involves a series of highly coordinated morphogenetic events that include cell migration, differentiation, growth, apoptosis, active fusion, and subsequent breakdown of the medial edge epithelium, as well as breakdown of the basement membrane. Any disturbance in these events may cause irreversible changes resulting in the development of facial clefts.
Some proteases, such as matrix metalloproteinases (MMPs), are responsible for remodeling of the extracellular matrix (ECM) and mediate changes in the basement membrane components of the medial edge seam during lip and palate fusion and their imbalance can lead to CLP (ref. 7 ). Several studies demonstrate that tissue remodeling by MMPs plays an important role in the late stages of lip and palate formation. Together with their endogenous tissue inhibitors (TIMPs) MMPs are generally rarely expressed in healthy tissues. Their expression increases during physiological or pathological tissue remodeling with the influence of signaling molecules able to modulate gene expression 8 . MMPs and TIMPs have been suggested to be candidate genes based on research of their spatial and temporal expression patterns during palatogenesis in animals 9 . Thus, the process of CLP morphogenesis is closely accompanied by changes in the composition of the extracellular matrix that promote cell migration and differentiation, cell-cell interactions, and tissue resorption.
This study investigated the expression of MMP-2, MMP-8, MMP-9, TIMP-2, and TIMP-4 in complete unilateral (CU), complete bilateral (CB) CLP to identify possible changes in signaling pathways that could lead to the abberant maxillofacial morphogenesis observed in CLP.
MATERIALS AND METHODS

Study population
The study was carried out according to the Declaration of Helsinki, and the protocal was independently reviewed and approved by the local Ethics Committee of Riga Stradins University. Written informed consent was obtained from all parents after the nature of the study had been fully explained.
Samples for the study were retrieved from the Cleft Lip and Palate Centre of the Institute of Stomatology of the Riga Stradins University. Forty-four CLP patients were enrolled. Twenty-five children had unilateral CLP, while 19 children had bilateral CLP. There were 19 boys and 6 girls in the unilateral CLP patients and 14 males and 5 females in the bilateral CLP patients.
In our study the tissue samples are not from the foetal period where the development of the lip and palate takes place but from fully development children aged (3 months and 8 years and 5 months). To attain optimal healing and hence cosmetic and functional results, a small piece of mucosa is routinely removed during the operation from borders of the cleft region. Patient samples were obtained during various surgeries, such as labioplasty, veloplasty and uranoplasty. Samples of oral mucosa were collected in upper labial frenectomy from control subjects ranging in age from 5 years to 7 years.
Tissue sample preparation
For conventional light microscopy and immunohistochemistry, tissue samples were fixed for one day in Stefanini's fixative for 24 h. After fixation, tissue blocks were embedded in paraffin. Three-micrometer thick sections were cut from each block, affixed onto the glass slides, then de-paraffinized in xylene, rehydrated through graded alcohol solutions and stained with hematoxylineosin.
Immunohistochemistry
Three-micrometer thick sections were cut from the same blocks and placed on adhesive microscope slides with silane treated surfaces for immunohistochemical analysis. Tissue sections were labeled with the following primary antibodies: mouse anti-MMP-2 at 1:100 (sc-53630; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), mouse anti-TIMP-2 at 1:100 (sc-21735; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), rabbit anti-MMP-9 at 1:100 (sc-10737; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), and rabbit anti-TIMP-4 at 1:100 (sc-30076; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). The slides were processed as follows: de-paraffinization; rehydrated through graded alcohol solutions; endogenous peroxidase activity was blocked by incubation with kit peroxidase blocking reagent for 10 minutes; the antibodies were diluted with the Antibody Diluent (64211; Abcam, Burlingame, CA, USA); HiDef Detection TM Amplifier (Mouse & Rabbit) (954D-31; Sigma-Aldrich, Rocklin, CA, USA) was applied for 10 minutes; HiDef Detection TM HRP Polymer Detector (954D-32; Sigma-Aldrich, Rocklin, CA, USA) was applied for 10 minutes and then stained with HRP-compatible chromogen for 5 min and counterstained in hematoxylin. For negative controls the primary antibody was replaced by a diluent.
Images were captured using a DC 300F camera (Leica, Wetzlar, Germany) and the image processing and analysis software Image Pro Plus v.6.0 (Media Cybernetics, Silver Spring, MD, USA). The intensity of immunostaining was graded semi-quantitatively on a scale of 0 to ++++, as follows: 0, no positive structures; 0/+, occasional positive structures; +, few immunoreactive structures; ++, a moderate number of immunoreactive structures; +++, numerous immunoreactive structures; and ++++, an abundance of immunoreactive structures in the visual field 10 .
Statistical analysis
Statistical analyses were performed using SPSS v.20.0 (IBM Corp., Armonk, NY, USA). Results are expressed as means ± SD. The Kruskal -Wallis test with Bonferroni correction were used to test significant difference between groups. The significance level was set at P < 0.05.
RESULTS
CBCLP
MMP-2 and MMP-8-positive structures were detected in all CBCLP cases, and the presence of MMP-2, MMP-8-positive epithelial cells was a few to abundant (Fig. 1,  2) . The number of MMP-2-positive connective tissue cells varied from occasional to numerous. Occasional MMP-8-positive connective cells were found in CBCLP specimens. Moderate numbers of immunoreactive structures were also observed in the salivary gland cells. In all CBCLP specimens, a few to moderate of TIMP-2-positive oral mucosa cells were seen. TIMP-2 immunoreactivity was detected in epithelial cells, fibroblasts, and macrophages. Of note, only a few isolated epithelial and connective tissue cells stained positively for MMP-9 and TIMP-4 in CBCLP affected tissue.
CUCLP
MMP-2-positive structures were present in all soft tissue samples, and immunoreactivity was detected in epithelial cells, fibroblasts, and macrophages. The number of MMP-2-positive epithelial cells varied from occasional to moderate but positive connective tissue cells were seen in a few to numerous positive structures. Furthermore, the number of TIMP-2-positive cells varied from occasional to numerous in all specimens but the presence of TIMP-4-positive epithelial cells and connective cells was a few to abundant (Fig. 3) . It is notable that the immunoreactivity for MMP-9 in CUCLP affected tissue was found in all tissue samples. Occasional to numerous immunoreactive cells were observed in epithelium and connective tissue (Fig. 4, 5) .
In all control specimens, only a few of MMP-2-positive epithelial cells were found (Fig. 6) . The total number of MMP-2-positive cells was significantly lower in the control than in the CBCLP group (P < 0.016). Notably, of the 10 control specimens, 9 were negative for MMP-2 in the connective tissue. There was significant difference between groups in the mean numbers of MMP-2-positive connective cells (P < 0.002; P < 0.005). This aside, the mean number of TIMP-2-positive connective cells was significantly lower in the control group than in the CLP groups (P < 0.005; P < 0.002). Further, the total number of MMP-2-positive cells was significantly lower in the CUCLP than in the CBCLP group (P < 0.001). The number of MMP-9-positive cells was significantly higher in the CUCLP than in the CBCLP group and controls (P < 0.001; P < 0.005). The total number of TIMP-4-positive cells also showed a significant decrease in the CBCLP and controls compared with that of the CUCLP (P < 0.001; P < 0.002). MMP-8 expression trends in the CLP groups were similar to those of the control group. There was no significant difference in mean numbers between groups.
DISCUSSION
In humans, morphogenesis of the lip and palate fusion is a highly regulated process involving the cooperation of different signalling molecules. The upper lip fusion promotes palate formation, and therefore improper lip fusion may secondarily affect palate fusion 11 . MMPs and TIMPs have the ability to participate in ECM remodelling during lip and palatal fusion and the EMT associated with this process. Controlled remodelling of the ECM is an essential aspect of craniofacial morphogenesis. Experiments in mice have suggested MMPs and TIMPs as potential candidate genes for CLP, based on expression patterns during palate morphogenesis 12 . If their balance is disrupted, birth defects, such as CLP, can occur. Although essential for the morphogenesis of craniofacial structures, MMPs and TIMPs have not been extensively studied in tissue samples obtained from fully developed children with CLP.
Mouse embryos show distinct temporospatial expression of MMP-2, MMP-3, MMP-7, MMP-9, MMP-13 and TIMP-1, TIMP-2 during palatal fusion. The inactivation of MMPs by TIMPs in vitro leads to a failure of fusion of mouse palatal shelves 13 . It has been reported that two MMP-mediated pathways are involved in palatal fusion, MMP-3 and the MMP-2/a cell membrane-associated MMP (MT1-MMP)/TIMP-2 pathway. Furthermore, a promoter variant in the TIMP-2 gene was associated with NSCLP in Europeans 14 . TIMP-2 is an inhibitor of MMPs and paradoxically it can function as a co-activator of pro-MMP-2 as well 15 . In our study, TIMP-2 positive cell distribution varied from a few to moderate positive structures in the patients examined, and TIMP-2 expression in the oral mucosa was lower in the control group than the CLP group. Particularly, elevated MMP-2 expression was observed in epithelial cells from patients with CBCLP. These results suggest the involvement of the MMP-2/MT-MMP/TIMP-2 pathway in the ECM remodelling directly associated with CBCLP.
The role of TIMP-4 local expression in humans CLP affected tissue has not been reported.
TIMP-4 may also play a role in activation of proM-MP-2. Interestingly, Zhang et al. (2003) suggested that TIMP-4 may indirectly regulate MMP-2 and MMP-9 gene transcription levels 16 . MMP-9 is known for its activity in degrading type IV collagen, the main component of the ECM, and facilitates cell migration 17 . Although Letra et al. (2007) provided no evidence of a major role for this gene in NSCLP (ref. 18 ), in this study elevated TIMP-4, MMP-9 expression was observed in epithelial cells, fibroblasts, and macrophages from patients with CUCLP and unaffected individuals. In contrast, there were fewer TIMP-4, MMP-9-positive cells in tissue samples from patients with CBCLP. These results show that lower MMP-9 expression might provide a predominantly scarring signal.
MMP-8 (collagenase-2) of the fibrillar collagenase family that also includes MMP-1 and MMP13, is particularly interesting in the context of CLP affected tissue remodelling because it can be expressed by a wide variety of cell types including epithelial cells, fibroblasts, endothelial cells, macrophages and neutrophil leukocytes 19 . It has been shown that MMP-8 is present in multiple embryonic tissues, including neural crest cells 20 . Tissues of the craniofacial complex are primarily derived from neural crest cells. Moreover, MMP-8 is expressed during many pathological conditions associated with excessive degradation of the ECM, such as periodontitis, osteoarthritis, chronic ulcers, and malignant tumours. This study shows that MMP-8-positive cell distribution varied from occasional to numerous positive structures in the patients. The results suggest involvement of MMP-8 locally in the breakdown of ECM in CLP affected tissue. 
CONCLUSIONS
The results of this study suggest that TIMP-4 and MMP-9 are the main ECM remodeling regulatory proteins expressed in CUCLP affected tissues of the oral mucosa. The increased expression of MMP-2 and TIMP-2 in CLP tissues implicates these factors in the regulation of cell migration during ECM turnover independently of different types of clefts. Investigation of MMP and TIMP expression in tissue samples obtained from patients with CLP is a promising approach to the etiopathogenesis of CLP.
